FINSEN TECHNOLOGIES LIMITED

Active London

Other human health activities

5 employees website.com
Healthcare and wellbeing Other human health activities
F

FINSEN TECHNOLOGIES LIMITED

Other human health activities

Founded 19 Oct 2012 Active London, United Kingdom 5 employees website.com
Healthcare and wellbeing Other human health activities

Previous Company Names

NANOCLAVE LIMITED 19 Oct 2012 — 29 Jan 2015
Accounts Submitted 19 Mar 2026 Next due 31 Mar 2026 2 months overdue
Confirmation Submitted 21 Oct 2025 Next due 2 Nov 2026 5 months remaining
Net assets £1M £154K 2024 year on year
Total assets £2M £229K 2024 year on year
Total Liabilities £420K £74K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

First Floor 5 Fleet Place London EC4M 7RD United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for FINSEN TECHNOLOGIES LIMITED (08260223), an active healthcare and wellbeing company based in London, United Kingdom. Incorporated 19 Oct 2012. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type total-exemption-full
Next accounts 31 Mar 2025
Due by 31 Mar 2026 2 months overdue

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£17.00k

Decreased by £229.86k (-93%)

Net Assets

£1.14M

Decreased by £154.44k (-12%)

Total Liabilities

£420.28k

Decreased by £74.38k (-15%)

Turnover

N/A

Employees

5

Increased by 2 (+67%)

Debt Ratio

27%

Decreased by 1 (-4%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 2

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

23 Allotments 28,836 Shares £18.57m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
6 Jan 2026195£1.95£0.01
18 Dec 202490£0.9£0.01
29 Oct 2024190£1.9£0.01
21 Jun 2023271£2.71£0.01
25 Nov 202239£0.39£0.01

Officers

Officers

2 active 1 resigned
Status
Adam Jan FudakowskiDirectorBritishEngland4219 Oct 2012Active
Stephen Luigi BertuzziSecretaryUnknownUnknown22 Apr 2020Active

Shareholders

Shareholders (15)

Nanoclave Technologies Llp
32.7%
9,388
Bill Passmore
21.3%
6,112

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Ceased

Group Structure

Group Structure

ANIMATRIX FOUNDERS LLP united kingdom
FINSEN TECHNOLOGIES LIMITED Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
18 May 2026OfficersTermination of Tristan John Williams as director on 30 Apr 2026
18 May 2026OfficersTermination of Benjamyn William Passmore as director on 30 Apr 2026
18 May 2026OfficersChange to director Tristan John Williams on 31 Jan 2022
19 Mar 2026AccountsAnnual accounts made up to 31 Mar 2025
18 Jan 2026CapitalAllotment of shares (GBP 289.32) on 6 Jan 2026
18 May 2026 Officers

Termination of Tristan John Williams as director on 30 Apr 2026

18 May 2026 Officers

Termination of Benjamyn William Passmore as director on 30 Apr 2026

18 May 2026 Officers

Change to director Tristan John Williams on 31 Jan 2022

19 Mar 2026 Accounts

Annual accounts made up to 31 Mar 2025

18 Jan 2026 Capital

Allotment of shares (GBP 289.32) on 6 Jan 2026

Recent Activity

Latest Activity

Termination of Tristan John Williams as director on 30 Apr 2026

1 weeks ago on 18 May 2026

Termination of Benjamyn William Passmore as director on 30 Apr 2026

1 weeks ago on 18 May 2026

Change to director Tristan John Williams on 31 Jan 2022

1 weeks ago on 18 May 2026

Annual accounts made up to 31 Mar 2025

2 months ago on 19 Mar 2026

Allotment of shares (GBP 289.32) on 6 Jan 2026

4 months ago on 18 Jan 2026